Francisco A. Arabía, MD, MBA, Carmelo A

Slides:

Advertisements

Similar presentations

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Advertisements

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L

What Predicts Long-Term Survival After Heart Transplantation

John C. Dykes, MD, Olaf Reinhartz, MD, Christopher S

Triple Bridge to Simultaneous Heart and Kidney Transplantation

Use of an Inexpensive Blue Band During Ventricular Assist Device and Total Artificial Heart Placement Facilitates and Expedites Explantation During Heart.

Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Implantation of HeartMate II Left Ventricular Assist Device in a Single-Lung Patient Hannah Copeland, MD, Liset Stoletniy, MD, Antoine Sakr, MD, Anees.

Improved Early Survival With a Nonsternotomy Approach for Continuous-Flow Left Ventricular Assist Device Replacement Matthew A. Schechter, MD, Chetan.

Berlin Heart EXCOR Ventricular Assist Device: Multilayer Membrane Rupture in a Pediatric Patient Arianna Di Molfetta, PhD, Sergio Filippelli, PhD, Gianfranco.

Pump Replacement for Left Ventricular Assist Device Failure Can Be Done Safely and Is Associated With Low Mortality Nader Moazami, MD, Carmelo A. Milano,

Laura Harvey, MD, Christopher Holley, MD, Samit S

Meindert Palmen, MD, PhD, Harriette F. Verwey, MD, PhD, Marlieke L. A

Long-Term Outcome for the Surgical Treatment of Infective Endocarditis With a Focus on Intravenous Drug Users David G. Rabkin, MD, Nahush A. Mokadam,

Robert C. Neely, MD, Robert Patrick Davis, PhD, Elizabeth H

Surgical Technique for Replacement of Centrifugal Left Ventricular Assist Device Through a Left Thoracotomy Carmelo A. Milano, MD The Annals of Thoracic.

Dhaval Chauhan, MD, Alexis K

An Extended Role of Continuous Flow Device in Pediatric Mechanical Circulatory Support Ed Peng, FRCS(CTh), Richard Kirk, FRCP, Neil Wrightson, BS, Phuoc.

Acquired von Willebrand Syndrome in Continuous-Flow Ventricular Assist Device Recipients Sheri Crow, MD, Dong Chen, MD, PhD, Carmelo Milano, MD, William.

Howard K. Song, MD, PhD, Frederick A

Jacob N. Schroder, MD, Mani A. Daneshmand, MD, Nestor R

The Optimal Timing of Stage-2-Palliation After the Norwood Operation

Sharven Taghavi, MD, MPH, Charisse Ward, MD, Senthil N

Implantable Continuous-Flow Right Ventricular Assist Device: Lessons Learned in the Development of a Cleveland Clinic Device Kiyotaka Fukamachi, MD,

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

Age-Related Outcomes of the Ross Procedure Over 20 Years

Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation? James K. Kirklin, MD, David C. Naftel,

Demographic, Psychosocial, and Behavioral Factors Associated With Survival After Heart Transplantation Steven A. Farmer, MD, PhD, Kathleen L. Grady,

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Outcomes in Patients Bridged With Univentricular and Biventricular Devices in the Modern Era of Heart Transplantation Joshua C. Grimm, MD, Christopher.

Clinical Experience With the MEDOS HIA-VAD System in Infants and Children: A Preliminary Report Wolfgang Konertz, MD, PhD, Holger Hotz, MD, Martin Schneider,

Origins of the Cardiothoracic Surgery Network (CTSNet)

Allen Cheng, MD, Erin M. Schumer, MD, MPH, Jaimin R

The Impact of Dominant Ventricle Morphology on Palliation Outcomes of Single Ventricle Anomalies Bahaaldin Alsoufi, MD, Scott Gillespie, MS, Dennis Kim,

Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle Masashi Kawabori, MD, Chitaru Kurihara, MD, Tadahisa.

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Left Ventricular Assist Device Inflow Angle and Pump Positional Change Over Time Adverse Impact on Left Ventricular Assist Device Function Toshinobu.

Comparative Effects of Ventricular Assist Device and Extracorporeal Membrane Oxygenation on Renal Function in Pediatric Heart Failure Parthak Prodhan,

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.

Michiaki Imamura, MD, PhD, Amy M

Colonization With Multiresistant Bacteria: Impact on Ventricular Assist Device Patients Maria Papathanasiou, MD, Julia Pohl, MD, Rolf Alexander Jánosi,

Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011 William L.

William L. Holman, MD, James K. Kirklin, MD, David C

John F. Lazar, MD, Michael F. Swartz, PhD, Matthew P

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Mechanical Circulatory Support Pathways That Maximize Post-Heart Transplant Survival Tara Karamlou, MD, MS, Jill Gelow, MD, Brian S. Diggs, PhD, Frederick.

Erik N. Sorensen, PhD, Richard N. Pierson, MD, Erika D

William M. Whited, MD, Paul Henley, BS, Erin M

Outcomes of Patients Receiving Temporary Circulatory Support Before Durable Ventricular Assist Device Palak Shah, MD, MS, Francis D. Pagani, MD, PhD,

Vacuum-Assisted Closure for the Treatment of Complex Chest Wounds

Ayesha S. Bryant, MSPH, William L. Holman, MD, Navin C

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Management of Empyema Cavity With the Vacuum-Assisted Closure Device

Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant.

Successful Conversion of TandemHeart Left Ventricular Assist Device to Right Ventricular Assist Device After Implantation of a HeartMate XVE Masami Takagaki,

Farhan Zafar, MD, John L. Jefferies, MD, MPH, Christine J

Iki Adachi, MD, Muhammad S. Khan, MD, Francisco A

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Infectious Complications in Patients With Left Ventricular Assist Device: Etiology and Outcomes in the Continuous-Flow Era Veli K. Topkara, MD, Sreekanth.

Y. Joseph Woo, MD, Michael A. Acker, MD The Annals of Thoracic Surgery

Ventricular Assist Device Implant in the Elderly Is Associated With Increased, but Respectable Risk: A Multi-Institutional Study Pavan Atluri, MD, Andrew.

Costs Associated With Ventricular Assist Device Use in Children

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

Kathleen E. Simpson, MD, Elizabeth Pruitt, MSPH, James K

Presentation transcript:

Biventricular Support With Intracorporeal, Continuous Flow, Centrifugal Ventricular Assist Devices Francisco A. Arabía, MD, MBA, Carmelo A. Milano, MD, Claudius Mahr, DO, Edwin C. McGee, MD, Nahush A. Mokadam, MD, J. Eduardo Rame, MD, Jaime D. Moriguchi, MD, Danny Ramzy, MD, PhD, David C. Naftel, PhD, Susan L. Myers, BBA QMIS, James K. Kirklin, MD The Annals of Thoracic Surgery Volume 105, Issue 2, Pages 548-555 (February 2018) DOI: 10.1016/j.athoracsur.2017.08.019 Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 (A) Left ventricle apical and right atrium cannulation. (B) Left ventricle apical and right ventricle cannulation. The Annals of Thoracic Surgery 2018 105, 548-555DOI: (10.1016/j.athoracsur.2017.08.019) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Survival of biventricular assist device (BI-VAD) versus centrifugal continuous flow (CCF) left ventricular assist device (LVAD) patients (blue line [n = 38; deaths, n = 10]) and CCF temporary right ventricular assist device (RVAD) patients (red line [n = 72; deaths, n = 24]). The Annals of Thoracic Surgery 2018 105, 548-555DOI: (10.1016/j.athoracsur.2017.08.019) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Competing outcomes at 6 months. (A) Centrifugal continuous flow (CCF) biventricular assist device (BiVAD): alive on original device (red line), 46%; transplanted, 25% (green line); dead, 30% (blue line), explant for recovery, 0%. (B) CCF left ventricular assist device (LVAD) plus temporary right ventricular assist device (RVAD): alive on original device, 43% (red line); transplanted, 29% (green line); dead, 28% (blue line), explant for recovery, 0%. The Annals of Thoracic Surgery 2018 105, 548-555DOI: (10.1016/j.athoracsur.2017.08.019) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Survival by right ventricle versus right atrium cannulation. Right ventricle assist device (RVAD) cannula inflow right atrium (blue line [n = 13; deaths, n = 2]); RVAD cannula inflow right ventricle (red line [n = 19; deaths, n = 8]). CCF = centrifugal continuous flow; LVAD = left ventricular assist device. The Annals of Thoracic Surgery 2018 105, 548-555DOI: (10.1016/j.athoracsur.2017.08.019) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions